Why the study?
To compare clinical characteristics, treatment patterns, and 30-day all-cause readmission and mortality in patients hospitalized for heart failure before versus during the COVID-19 pandemic.
Does hospitalization during the COVID-19 pandemic alter 30-day all-cause readmission and mortality in patients with heart failure?
Does hospitalization during the COVID-19 pandemic alter 30-day all-cause readmission and mortality in patients with heart failure?
During the COVID-19 pandemic, patients hospitalized for heart failure experienced lower 30-day readmission rates but higher 30-day all-cause mortality compared to the pre-pandemic period.
No takes yet. Share an insight, caveat, or question.
Elevated post-HF hospitalization mortality during COVID-19 signals need for heightened monitoring; leaves open mechanisms and generalizability beyond this cohort.
Yousufuddin et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: